$3.620
-0.107 (-2.95%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TSHA Prediction & Forecast by Similar Chart Analysis
Alphio's TSHA stock price prediction model matches the current Taysha Gene Therapies Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.63 (+0.19%). The 1-week path is $3.65 (+0.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Taysha Gene Therapies Inc Stock?
Taysha Gene Therapies Inc is currently not a good buy due to its low current price of $3.62, which is significantly below analyst price targets ranging from $10 to $15. However, the stock is experiencing high volatility with an RSI of 24.29, indicating it may be oversold. The main risk is the negative earnings trend, with a net income loss of $46.6 million in Q2 2026, which raises concerns about the company's financial health.
TSHA stock price ended at $3.62 on Friday, after losing -2.95%
Taysha Gene Therapies Inc (TSHA) last closed at $3.62, losing -2.95%. These facts feed the 1-day and 1-week TSHA price prediction above.
Forecast Drivers
Taysha Gene Therapies Inc (TSHA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TSHA, ranked by similarity.
Seasonality analysis for TSHA
Historically the probability of a positive October return for TSHA is 77.59%. June offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TSHA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $1.55 | $1.56 | $1.64 | -56.95% |
| Nov 2026 | $1.52 | $1.66 | $1.69 | -54.16% |
| Dec 2026 | $1.10 | $1.30 | $1.65 | -64.13% |
In 2026, Taysha Gene Therapies Inc (TSHA) is projected to range from $1.10 to $1.69.
Taysha Gene Therapies Inc 2026 monthly forecast
In Oct 2026, Taysha Gene Therapies Inc is projected to average $1.56, with a low of $1.55 and high of $1.64.
In Nov 2026, Taysha Gene Therapies Inc is projected to average $1.66, with a low of $1.52 and high of $1.69.
In Dec 2026, Taysha Gene Therapies Inc is projected to average $1.30, with a low of $1.10 and high of $1.65.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.